Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients

doi:10.3748/wjg.v12.i45.7319

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3938)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

353

HTML

3142

Figures (1-3)

230

Tables (1-3)

213

Sum=3938

Dec 7, 2006 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (57)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 7, 2006; 12(45): 7319-7325
Published online Dec 7, 2006. doi: 10.3748/wjg.v12.i45.7319

Open in New Tab Full Size Figure Download Figure

Figure 1 Staging of tumors according to the modified TNM classification for liver transplantation[24]. T0: Tumor not found; T1: 1 nodule < 1.9 cm; T2: 1 nodule 2.0-5 cm; 2 or 3 nodules, all <3 cm; T3: 1 nodule > 5.0 cm; 2 or 3 nodules, at least 1 > 3.0 cm; T4a: 4 or more nodules, any size; T4b: T2, T3, T4a plus gross intrahepatic portal or hepatic vein involvement as indicated by US, CT or MRI; N1: Involvement of regional (porta hepatitis) nodes; N2: Metastatic disease, including extrahepatic portal or hepatic vein involvement.

Open in New Tab Full Size Figure Download Figure

Figure 2 Overall 5-year disease-free survivals.

Open in New Tab Full Size Figure Download Figure

Figure 3 Influence of immunosuppession (A), tumor differentiation (B) and size (C) on tumor-recurrence free survival.

Citation: Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, Bernard PH, Boillot O, Compagnon P, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Dharancy S, Chazouillères O, Cherqui D, Duvoux C. Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients. World J Gastroenterol 2006; 12(45): 7319-7325
URL: https://www.wjgnet.com/1007-9327/full/v12/i45/7319.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i45.7319